Skip to main content
SpringerLink
Log in

Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy

Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Hypertension is often seen in Type 1 and Type 2 diabetic patients, particularly in those with nephropathy, and the progression of diabetic nephropathy is closely related to blood pressure elevation. Thus, the effects of antihypertensive drugs on kidney function and insulin sensitivity in diabetic patients are of great clinical importance.

Successful antihypertensive treatment has been shown to slow the progression of diabetic nephropathy. Several results from short term studies have suggested that angiotensin converting enzyme (ACE) inhibitors may be advantageous over other conventional antihypertensive agents in reducing albuminuria in both hypertensive and normotensive diabetics with microalbuminuria or persistent proteinuria. However, the decline in glomerular filtration rate during ACE inhibitor treatment is comparable to that during effective treatment with conventional antihypertensive drugs in hypertensive Type 1 diabetic patients with overt nephropathy. Whether ACE inhibitors possess a specific effect in preventing the development of diabetic nephropathy remains to be seen in properly designed long term studies. Although calcium antagonists may preserve kidney function or possess a renoprotective effect in hypertensive Type 2 diabetics with nephropathy, firm evidence supporting this contention seems to be lacking and also requires long term evaluation.

Increasing attention is being directed toward the effect of antihypertensive drugs on insulin sensitivity in diabetic patients: ACE inhibitors and α-adrenoceptor blocking agents have been shown to improve this sensitivity. Despite the widespread involvement of calcium in hormone secretion and action, calcium antagonists appear to have little effects on the glucoregulatory and calcium-regulatory hormones within the drug dosages used in clinical practice.

Several clinical variables, such as the presence or absence of hypertension, overt nephropathy and microalbuminuria, or a combination of variables should be accounted for when evaluating critically the cumulative data on the effects of antihypertensive drugs on kidney function and albuminuria in the variety of diabetic patient groups. Understanding the pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs will be of clinical importance in diabetic patients with advanced nephropathy (glomerular filtration rate of < 30 ml/min) and/or other complications, such as impaired gastric motility or gastroparesis, and will thereby lead to a more rational management of hypertension in those patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983

    PubMed  CAS  Google Scholar 

  • Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy. American Journal of Medicine 89: 811–813, 1990

    PubMed  CAS  Google Scholar 

  • Baba T, Boku A, Ishizaki T, Sone K, Takebe K. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension. American Heart Journal 111: 552–557, 1986a

    PubMed  CAS  Google Scholar 

  • Baba T, Ishizaki T, Ido Y, Aoyagi K, Murabayashi S, et al. Renal effects of nicardipine, a calcium entry blocker, in hypertensive type II diabetic patients with nephropathy. Diabetes 35: 1206–1214, 1986b

    PubMed  CAS  Google Scholar 

  • Baba T, Ishizaki T, Murabayashi S, Aoyagi K, Tamasawa N, et al. A multiple oral dose of nicardipine: effects on renal function, plasma renin activity and plasma aldosterone concentration in patients with mild-to-moderate essential hypertension. Clinical Pharmacology and Therapeutics 42: 232–239, 1987

    PubMed  CAS  Google Scholar 

  • Baba T, Kodama T, Takebe K. Enalapril and metoprolol in diabetic nephropathy. Correspondence. British Medical Journal 300: 1399, 1990a

    Google Scholar 

  • Baba T, Kodama T, Tomiyama T, Fujita N, Takebe K. Hyperinsulinaemia and blood pressure in non-obese, middle-aged Japanese subjects with normal glucose tolerance. Tohoku Journal of Experimental Medicine, in press, 1992

    Google Scholar 

  • Baba T, Murabayashi S, Aoyagi K, Sasaki K, Imamura K, et al. Prevalence of hypertension in diabetes mellitus: its relation to diabetic nephropathy. Tohoku Journal of Experimental Medicine 145: 167–173, 1985

    PubMed  CAS  Google Scholar 

  • Baba T, Murabayashi S, Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia 32: 40–44, 1989a

    PubMed  CAS  Google Scholar 

  • Baba T, Murabayashi S, Tomiyama T, Takebe K. Uncontrolled hypertension is associated with a rapid progression of nephropathy in Type 2 diabetic patients with proteinuria and preserved renal function. Tohoku Journal of Experimental Medicine 161: 311–318, 1990b

    PubMed  CAS  Google Scholar 

  • Baba T, Murabayashi S, Tomiyama T, Takebe K. Renal effects of calcium entry blocker, nicardipine, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy. European Journal of Clinical Pharmacology 38: 425–429, 1990c

    PubMed  CAS  Google Scholar 

  • Baba T, Sawicki P. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rats: are these effects specific for enalapril? Correspondence. Diabetologia 32: 829, 1989

    PubMed  CAS  Google Scholar 

  • Baba T, Tomiyama T, Murabayashi S, Tomiyama M, Takebe K. Pharmacokinetics of ACE inhibitor in diabetic patients. Correspondence. Lancet 1: 226–227, 1989b

    PubMed  CAS  Google Scholar 

  • Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Annals of Internal Medicine 112: 707–708, 1990

    PubMed  CAS  Google Scholar 

  • Bank N, Klose R, Aynedijian HS, Nguyen D, Sablay LB. Evidence against increased glomerular pressure inhibiting diabetic nephropathy. Kidney International 31: 898–905, 1987

    PubMed  CAS  Google Scholar 

  • Bauer JH, Reams GP. Renal effects of angiotensin converting enzyme inhibitors in hypertension. American Journal of Medicine 81 (Suppl. 4C): 19–27, 1986

    PubMed  CAS  Google Scholar 

  • Bedford Johnson BA, Sowers JR, Zemel PC, Luft FC, Zemei MB. Increased sodium-lithium countertransport in black non-insulin-dependent diabetic hypertensives. American Journal of Hypertension 3: 563–565, 1990

    Google Scholar 

  • Bejar MAC, Arrieta FJ, Cordiodo F, Casado S, Herrera Pombo JL. Beneficial effect of captopril on proteinuria and blood pressure in diabetic patients. Abstract. Diabetologia 30: 505A, 1987

    Google Scholar 

  • Beretta-Piccoli C, Weidmann P. Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus. American Journal of Medicine 71: 829–836, 1981

    PubMed  CAS  Google Scholar 

  • Berg KJ, Holdaas H, Djoseland O, Lien MG, Nilsen L, et al. Short-term effects of lisinopril and nifedipine in diabetic nephropathy. Abstract. 2nd Meeting of the European Diabetic Nephropathy Meeting of the European Diabetic Nephropathy Study Group, Aarhus, May 12–13, 1989

  • Björck S, Mulec H, Johnsen SA, Nyberg G, Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. British Medical Journal 300: 904–907, 1990

    PubMed  Google Scholar 

  • Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. British Medical Journal 293: 471–474, 1986

    PubMed  Google Scholar 

  • Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, et al. Diabetic nephropathy — an inherited complication? Abstract. Diabetologia 33: A30, 1990

    Google Scholar 

  • Brouhard BH, LaGrone L. Effect of dietary protein restriction on functional renal reserve in diabetic nephropathy. American Journal of Medicine 89: 427–431, 1990

    PubMed  CAS  Google Scholar 

  • Capps N, Bottomley S, Havard F, Tymms DJ, O’Hare JP. Low dose captopril does not reduce protein excretion in diabetics with incipient nephropathy. Abstract. Diabetic Medicine 6 (Suppl. 1): A3, 1988

    Google Scholar 

  • Carr S, Mbanya J-C, Thomas T, Keavery P, Taylor R, et al. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. New England Journal of Medicine 322: 500–505, 1990

    PubMed  CAS  Google Scholar 

  • Charles S, Ketelsleger JM, Buysschaert M, Lambert AE. Hyperglycaemic effect of nifedipine. British Medical Journal 289: 19–20, 1981

    Google Scholar 

  • Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies on albumin excretion and blood pressure. Diabetic Medicine 2: 97–102, 1985a

    PubMed  CAS  Google Scholar 

  • Christensen CK, Mogensen CE. Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 7 (Suppl. II): 109–113, 1985b

    Google Scholar 

  • Christensen CK, Pedersen MM, Mogensen CE. Long-term effect of ACE-inhibition on albumin excretion (UAE), blood pressure and renal hemodynamics in type 1 IDDM patients with early diabetic nephropathy, already treated with selective beta-blocker and diuretics. 2nd International Symposium on Hypertension Associated with Diabetes Mellitus, Paris, Abstract, p. 32, 1988

  • Christlieb AR. Treatment selection considerations for the hypertensive diabetic patients. Archives of Internal Medicine 150: 1167–1174, 1990

    PubMed  CAS  Google Scholar 

  • Christlieb AR, Warram JH, Krowlewski AS, Busick EJ, Ganda OM. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 30 (Suppl. 2): 90–96, 1981

    PubMed  CAS  Google Scholar 

  • Ciavarella A, Di Mizio G, Stefoni S, Borgnino LC, Vannini P. Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy. Diabetes Care 10: 407–413, 1987

    PubMed  CAS  Google Scholar 

  • Cleland JGF, Dargie HJ. Arrhythmias, catecholamines and electrolytes. American Journal of Cardiology 62: 55A–59A, 1988

    PubMed  CAS  Google Scholar 

  • Cohen ML, Kurz KD. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. Journal of Pharmacology and Experimental Therapeutics 20: 63–69, 1982

    Google Scholar 

  • Collins WC, Cullen MJ, Feely J. Calcium channel blocker drugs and diabetic control. Clinical Pharmacology and Therapeutics 42: 420–423, 1987

    PubMed  CAS  Google Scholar 

  • Cook J, Daneman D, Spino M, Sochett E, Perlman K, et al. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. Journal of Pediatrics 117: 39–45, 1990

    PubMed  CAS  Google Scholar 

  • Cooper ME, Allen TJ, Macmillan PA, Clarke BE, Jerums G, et al. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rats. Diabetologia 32: 326–328, 1989

    PubMed  CAS  Google Scholar 

  • Cooper ME, Allen TJ, Macmillan PA, Jerums G, Doyle AE. Experimental diabetic nephropathy — the role of genetic hypertension and antihypertensive therapy. 2nd International Symposium on Hypertension Associated with Diabetes Mellitus, Paris, September 8–10, Abstract, p. 19, 1988

  • Cooper ME, Allen TJ, O’Brien RC, Papazoglou D, Clarke BE, et al. Nephropathy in model combining genetic hypertension with experimental diabetes: enalapril versus hydralazine and metoprolol therapy. Diabetes 39: 1575–1579, 1990

    PubMed  CAS  Google Scholar 

  • Cruickshank JK, Anderson NMcF, Wadsworth J, McHardy Young S, Jepson E. Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol. British Medical Journal 297: 1155–1159, 1988

    PubMed  CAS  Google Scholar 

  • Cubeddu LX, Aranda J, Singh B, Klein M, Brachfeld J, et al. Comparison of verapamil and propranolol for the initial treatment of hypertension: racial difference in response. Journal of American Medical Association 256: 2214–2221, 1986

    CAS  Google Scholar 

  • Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. American Journal of Hypertension 2: 294–306, 1989

    PubMed  CAS  Google Scholar 

  • Damsgarrd EM, Mogensen CE. Microalbuminuria in elderly hyperglycaemic patients and controls. Diabetic Medicine 3: 430–435, 1986

    Google Scholar 

  • D’Angelo A, Sartori L, Gambaro G, Giiannini S, Malvasi L, et al. Captopril in the treatment of hypertension in type I and type II diabetic patients. Postgraduate Medical Journal 62 (Suppl.): 69–72, 1986

    PubMed  Google Scholar 

  • Deckert T, Feldt-Rasmussen B, Borch-Johsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32: 219–226, 1989

    PubMed  CAS  Google Scholar 

  • Deckert T, Poulsen JE. Diabetic nephropathy: fault or destiny? Diabetologia 21: 178–183, 1981

    PubMed  CAS  Google Scholar 

  • DeFronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 21: 165–171, 1981

    PubMed  CAS  Google Scholar 

  • Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Annals of Internal Medicine 113: 987–988, 1990

    PubMed  CAS  Google Scholar 

  • Dørup I, Skajaa K, Clausen T, Kjeldsen K. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. British Medical Journal 296: 455–458, 1988

    PubMed  Google Scholar 

  • Doyle AE, Martin FIR, Alford F, Jerums G, Mashford ML, et al. A comparison of the effects of blood pressure reduction with perindopril and nifedipine on microalbuminuria in hypertensive and normotensive type I and type II diabetics. 2nd International Symposium on Hypertension Associated with Diabetes Mellitus, Paris, Abstract p. 32, 1988

  • Drummond K, Levy-Marchal C, Laborde K, Kindermans C, Wright C, et al. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering Type 1 (insulin-dependent) diabetic children. Diabetologia 32: 255–260, 1989

    PubMed  CAS  Google Scholar 

  • Drury PL. Diabetes and arterial hypertension. Diabetologia 24: 1–9, 1983

    PubMed  CAS  Google Scholar 

  • Drury PL, Smith GM, Feeris JB. Increased vasopressor responsiveness to angiotensin II in Type I (insulin-dependent) diabetic patients without complications. Diabetologia 27: 174–179, 1984

    PubMed  CAS  Google Scholar 

  • Dullaart RPF, Dkkeschei LD, Doorenbos H. Alterations in serum lipids and apolipoproteins in male Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 32: 685–689, 1989

    PubMed  CAS  Google Scholar 

  • Dunn BR, Zatz R, Rennke HGr, Meyer TW, Anderson S, et al. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury. Journal of Hypertension 4 (Suppl. 5): S251–S254, 1986

    PubMed  CAS  Google Scholar 

  • Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J. Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 20: 190–194, 1981

    PubMed  CAS  Google Scholar 

  • Elving L, de Norel E, van’t Laar A. Effect of captopril on diabetic proteinuria. Correspondence. New England Journal of Medicine 315: 515–516, 1986

    Google Scholar 

  • Evanoff GV, Thompson C, Brown J, Weinman EJ. The effect of dietary protein restriction on the progression of diabetic nephropathy. Archives of Internal Medicine 147: 492–495, 1987

    PubMed  CAS  Google Scholar 

  • Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT. The kidney in maturity-onset diabetes mellitus: a clinical study of 510 patients. Kidney International 21: 730–738, 1982

    PubMed  CAS  Google Scholar 

  • Faguer de Moustier B, Paoli V. The influence of nicardipine in Type 2 diabetic patients with slight hypertension. Journal of Cardiovascular Pharmacology 16 (Suppl. 2): S26–S33, 1990

    PubMed  Google Scholar 

  • Feldt-Rasmussen B. ACE inhibitors vs calcium channel blockers in hypertension in NIDDM. International Diabetes Monitoring 1: 7–8, 1989

    Google Scholar 

  • Feldt-Rasmussen B, Mathiesen E, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304, 1986

    PubMed  CAS  Google Scholar 

  • Felicetta JV, Sowers JR. Systemic hypertension in diabetes mellitus. American Journal of Cardiology 61: 34H–40H, 1988

    PubMed  CAS  Google Scholar 

  • Felici MG, Frontoni S, Bacci S, Gagiulo P, Cancelli A, et al. ACE-inhibitors in incipient diabetic nephropathy. 2nd International Symposium on Hypertension Associated with Diabetes Mellitus, Paris, Abstract, p. 32, 1988

  • Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, et al. Insulin resistance in essential hypertension. New England Journal of Medicine 317: 350–357, 1987

    PubMed  CAS  Google Scholar 

  • Ferrannini E, DeFronzo RA. The association of hypertension, diabetes and obesity: a review. Journal of Nephrology 1: 3–15, 1989

    Google Scholar 

  • Fernere M, Lachkar H, Richard J-L, Bringer J, Orsetti A, et al. Captopril and insulin sensitivity. Correspondence. Annals of Internal Medicine 102: 135–136, 1985

    Google Scholar 

  • Frank HJL. Hypertension in the elderly diabetics: therapeutic aspects. Journal of Hypertension 6 (Suppl. 1): S109–S111, 1988

    PubMed  CAS  Google Scholar 

  • Friedmann PJ, Dunn PJ, Jury DR. Metoprolol and albumin excretion in diabetes. Correspondence. Lancet 2: 1042–1043, 1986

    Google Scholar 

  • Friedman R, Gross JL. Evolution of glomerular filtration rate in proteinuric NIDDM patients. Diabetes Care 14: 355–359, 1991

    PubMed  CAS  Google Scholar 

  • Fujita N, Baba T, Tomiyama T, Kodama T, Kako N. Hyperinsulinaemia and blood pressure in patients with insulinoma. British Medical Journal, in press, 1992

    Google Scholar 

  • Fuller JH. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 7 (Suppl. II): II8–II13, 1985

    Google Scholar 

  • Gambaro G, Morbiato F, Ciceello E, Del Turco M, Sartori L, et al. Captopril in the treatment of hypertension in Type I and Type II diabetic patients. Journal of Hypertension 3 (Suppl. 2): S149–S151, 1985

    PubMed  CAS  Google Scholar 

  • Gavras H. Angiotensin converting enzyme inhibition and its impact on cardiovascular disease. Circulation 81: 381–388, 1990

    PubMed  CAS  Google Scholar 

  • Giorato C, Trevisan R, Fioretto P, Morocutti A, Doria A, et al. Effects of ACE-inhibitor treatment on kidney function in normotensive and hypertensive Type I (insulin-dependent) diabetic patients. Abstract. Diabetologia 31: 49A, 1988

    Google Scholar 

  • Giugliano D, Torella R, Cacciapuotic F, Gentile S, Verza M, et al. Impairment of insulin secretion in man by nifedipine. European Journal of Clinical Pharmacology 18: 395–398, 1981

    Google Scholar 

  • Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, et al. Non-insulin-dependent diabetes and renal replacement therapy. Diabetic Medicine 5: 172–176, 1988

    PubMed  CAS  Google Scholar 

  • Grodsky GM, Bennett LL. Cation requirements for insulin secretion in the isolated perfused pancreas. Diabetes 15: 910–913, 1966

    PubMed  CAS  Google Scholar 

  • Gwilt PR, Nahhas RR, Tracewell WG. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clinical Pharmacokinetics 20: 477–490, 1991

    PubMed  CAS  Google Scholar 

  • Hartford M, Wendelhag I, Berglund G, Wallentin I, Ljungman S, et al. Cardiovascular and renal effects of long-term anti-hypertensive treatment. Journal of American Medical Association 259: 2553–2557, 1988

    CAS  Google Scholar 

  • Hay U, Ludvik B, Gisinger CH, Schernthaner G. Fehlender Effekt der ACE-Inhibition auf die Makroproteinurie bei Diabetischer Nephropathie — eine Langzeitstudie uber 6 Monate. Schweizerische Medizinische Wochenschrift 118: 165–169, 1988

    PubMed  CAS  Google Scholar 

  • Holm G, Johansson S, Vedin A, Wilhelmsson C, Smith U. The effect of beta-blockade on glucose tolerance and insulin release in adult diabetes. Acta Medica Scandinavica 208: 187–191, 1980

    PubMed  CAS  Google Scholar 

  • Hommel E, Parving H-H, Mathiesen E, Edsberg B, Nielsen MD, et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British Medical Journal 293: 467–470, 1986

    PubMed  CAS  Google Scholar 

  • Houston MC. Treatment of hypertension in diabetes mellitus. American Heart Journal 118: 819–829, 1989

    PubMed  CAS  Google Scholar 

  • Insua A, Ribstein J, Mimran A. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Postgraduate Medical Journal 64 (Suppl. 3): 59–62, 1988

    PubMed  Google Scholar 

  • Jarrett RJ. The epidemiology of coronary heart disease and related factors in the context of diabetes mellitus and impaired glucose tolerance. In Jarrett RJ (Ed), Diabetes and heart disease, pp. 1–23, Elsevier, Amsterdam, 1984

    Google Scholar 

  • Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, et al. Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabetic Medicine 1: 17–19, 1984

    PubMed  CAS  Google Scholar 

  • Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, et al. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 17: 448–454, 1987

    PubMed  CAS  Google Scholar 

  • Jensen T, Borch-Johnsen K, Deckert T. Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy. Diabetes Research 4: 159–160, 1987

    PubMed  CAS  Google Scholar 

  • Jensen JS, Mathiesen ER, Norgaard K, Hommel E, Borch-Johnsen K, et al. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 33: 619–624, 1990

    PubMed  CAS  Google Scholar 

  • Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, et al. Plasma lipid and coagulation factor concentrations in insulin-dependent diabetics with microalbuminuria. British Medical Journal 298: 487–490, 1989

    PubMed  CAS  Google Scholar 

  • Khan MIG. Manual of cardiac drug therapy. Bailliere Tindall, Eastbourne, 1985

    Google Scholar 

  • Kaplan NM. Calcium entry blockers in the treatment of hypertension: current status and future prospects. Journal of American Medical Association 262: 817–823, 1989

    CAS  Google Scholar 

  • Kaplan NM, Rosenstock J, Raskin P. A differing view of treatment of hypertension in patients with diabetes mellitus. Archives of Internal Medicine 147: 1160–1162, 1987

    PubMed  CAS  Google Scholar 

  • Kappel D, Van Tuinen M. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975–1984. American Journal of Kidney Disease 8: 234–238, 1986

    CAS  Google Scholar 

  • Kelleher CC. ACE inhibitors in the prevention and therapy of diabetic nephropathy: what is their role? Drugs 39: 639–645, 1990

    PubMed  CAS  Google Scholar 

  • Kelleher CC, Ferriss JB, Cole M, O’Sullivan DJ. Enalapril and microalbuminuria in diabetic and non-diabetic hypertension. Journal of Human Hypertension 1: 181–183, 1987

    PubMed  CAS  Google Scholar 

  • Kelly JG, O’Malley K. Clinical pharmacokinetics of the newer ACE inhibitors: a review. Clinical Pharmacokinetics 19: 177–196, 1990

    PubMed  CAS  Google Scholar 

  • Klein BE, Klein R, Moss SE. Blood pressure in a population of diabetic persons diagnosed after 30 years of age. American Journal of Public Health 74: 336–339, 1984

    PubMed  CAS  Google Scholar 

  • Knowler WV, Bennett PH, Nelson RG, Saad MF, Pettitt DJ. Blood pressure before the onset of diabetes predicts albuminuria in Type 2 (non-insulin-dependent) diabetes. Abstract. Diabetologia 31: 509A, 1988

    Google Scholar 

  • Kodama T, Baba T, Tomiyama T, Takebe K. Cardiovascular risk factors in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Abstract. Diabetologia 33: A48, 1990

    Google Scholar 

  • Kodama J, Katayama S, Tanaka K, Itabashi A, Kawazu S, et al. Effect of captopril on glucose concentration: possible role of augmented postprandial forearm blood flow. Diabetes Care 13: 1109–1111, 1990

    PubMed  CAS  Google Scholar 

  • Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 36: 205–209, 1987

    PubMed  CAS  Google Scholar 

  • Krolewski AS, Warram JH, Christlieb AR. Onset, course, complications, and prognosis of diabetes mellitus. In Marble A, et al. (Eds) Joslin’s Diabetes Mellitus, 12th ed., pp. 251–277, Lea & Febiger, Philadelphia, 1985a

    Google Scholar 

  • Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. Changing natural history of nephropathy in type 1 diabetes. American Journal of Medicine 78: 785–794, 1985b

    PubMed  CAS  Google Scholar 

  • Krolewski AS, Warram JH, Cupples A, Gorman CK, Szabo AJ, et al. Hypertension, orthostatic hypotension and the microvascular complications of diabetes. Journal of Chronic Disease 38: 319–326, 1985c

    CAS  Google Scholar 

  • Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH. Incidence of proteinuria in Type 2 diabetes mellitus in the Pima Indians. Kidney International 35: 681–687, 1989

    PubMed  CAS  Google Scholar 

  • Kupin WL, Cortes P, Dumler F, Feldkamp CS, Kilates MC, et al. Effect on renal function of change from high to moderate protein intake in Type I diabetic patients. Diabetes 36: 73–79, 1987

    PubMed  CAS  Google Scholar 

  • Lewis PJ, Kohner EM, Petrei A, Witte DL. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet 1: 564–566, 1976

    PubMed  CAS  Google Scholar 

  • Lipson LG. Special problems in treatment of hypertension in the patients with diabetes mellitus. Archives of Internal Medicine 144: 1829–1831, 1984

    PubMed  CAS  Google Scholar 

  • Loutzenhiser R, Epstein M. Effects of calcium antagonists on renal hemodynamics. American Journal of Physiology 249: F619–F629, 1985

    PubMed  CAS  Google Scholar 

  • Malaisse WJ, Mathias PC. Stimulation of insulin release by an organic calcium agonist. Diabetologia 28: 153–156, 1985

    PubMed  CAS  Google Scholar 

  • Mangili R, Bending JJ, Scott G, Li LK, Gupta A, et al. A marker for diabetic nephropathy: increased RBC Na+/Li+ exchanger activity. Abstract. Diabetes 36 (Suppl. 1): 43A, 1987

    Google Scholar 

  • Mann S, Altman DG, Raftery EB, Bannister R. Orcadian variation of blood pressure in autonomic failure. Circulation 68: 477–483, 1983

    PubMed  CAS  Google Scholar 

  • Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. British Medical Journal 297: 1092–1095, 1988

    PubMed  CAS  Google Scholar 

  • Marre M, Fressinaud P. Clinical effects of calcium antagonists in hypertensive diabetics. Journal of Cardiovascular Pharmacology 16 (Suppl. 2): S13–S15, 1990

    PubMed  Google Scholar 

  • Marre M, Leblanc H, Suarez L, Guyenne T, Menard J, et al. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. British Medical Journal 294: 1448–1452, 1987

    PubMed  CAS  Google Scholar 

  • Marre M, Suraniti S, Hallab M, Page JD, Billiard A, et al. Role of essential hypertension in urinary albumin excretion of Type 2, non-insulin-dependent diabetics. Abstract. Diabetologia 33: 210A, 1990

    Google Scholar 

  • Martin P, Hampton KK, Walton C, Tindall H, Davies JA. Microalbuminuria in Type 2 diabetes mellitus from diagnosis. Diabetic Medicine 7: 315–318, 1990

    PubMed  CAS  Google Scholar 

  • Massie B, MacCarthy EP, Ramanathan KB, Weis RJ, Anderson M, et al. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. Annals of Internal Medicine 107: 150–157, 1987

    PubMed  CAS  Google Scholar 

  • Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. British Medical Journal 303: 81–87, 1991

    PubMed  CAS  Google Scholar 

  • Mathiesen ER, Oxenboll K, Johansen PA, Svendsen PA. Incipient nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984

    PubMed  CAS  Google Scholar 

  • Mattock MB, Keen H, Viberti GC, El-Gohri MR, Murrels TJ, et al. Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 82–87, 1988

    PubMed  CAS  Google Scholar 

  • Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. British Medical Journal 302: 210–216, 1991

    Google Scholar 

  • Micossi P, Pollavini G, Raggi U, Librenti MC, Garimberti B, et al. Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus. Hormone and Metabolic Research 16: 59–63, 1984

    PubMed  CAS  Google Scholar 

  • Miller JM. Diabetes mellitus and hypertension in black and white populations. Southern Medical Journal 79: 1229, 1986

    PubMed  CAS  Google Scholar 

  • Mimran A, Insua A, Ribstein J, Monnier L, Bringer J, et al. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Journal of Hypertension 6: 919–923, 1988

    PubMed  CAS  Google Scholar 

  • Modan M, Halkin H, Almog S, Lusky A, Eshkol A, et al. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. Journal of Clinical Investigation 75: 809–817, 1985

    PubMed  CAS  Google Scholar 

  • Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scandinavian Journal of Clinical and Laboratory Investigation 36: 383–388, 1976

    PubMed  CAS  Google Scholar 

  • Mogensen CE. Diabetes and hypertension. Lancet 1: 388–389, 1979

    PubMed  CAS  Google Scholar 

  • Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. British Medical Journal 285: 685–688, 1982

    PubMed  CAS  Google Scholar 

  • Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. New England Journal of Medicine 310: 356–360, 1984

    PubMed  CAS  Google Scholar 

  • Mogensen CE. Management of the diabetic patient with hypertension: early screening and treatment programs. In Laragh JH, Brenner BM (Eds) Hypertension: pathophysiology, diagnosis, and management, pp. 1717–1739, Raven Press, Ltd, New York, 1990

    Google Scholar 

  • Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. New England Journal of Medicine 311: 89–93, 1984

    PubMed  CAS  Google Scholar 

  • Mohamed AS, Yaqoob M, Bell GM. Angiotensin-converting enzyme-inhibitors in diabetics with hypertension: a cautionary note. Nephron 55: 83–84, 1990

    PubMed  CAS  Google Scholar 

  • Moser M, Lunn J, Nash DT, Bums JF, Winer N, et al. Nitrendipine in the treatment of mild to moderate hypertension. Journal of Cardiovascular Pharmacology 6 (Suppl. 7): S1085–S1089, 1984

    PubMed  Google Scholar 

  • Moser M, Lunn J, Materson BJ. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension. American Journal of Cardiology 56: 101H–104H, 1985

    PubMed  CAS  Google Scholar 

  • Naber SP, McDonald JM, Jarett ML, McDaniel CW, Ludvigsen CW, et al. Primary characterization of calcium binding in islet-cell plasma membranes. Diabetologia 19: 439–444, 1980

    PubMed  CAS  Google Scholar 

  • Narkiewicz K, Rynkiewicz A, Furmanski J, Gan J, Kubasik A, et al. Relationship between fasting plasma insulin and ambulatory blood pressure in young, non-obese normotensive subjects. Journal of Hypertension 9: 505–507, 1991

    PubMed  CAS  Google Scholar 

  • O’Brien T, Young WF, Palumbo PJ, O’Brien PC, Service FJ. Is the hyperinsulinemia of insulinoma associated with hypertension and hypertriglyceridema? Abstract. Diabetologia 34 (Suppl. 2): A19, 1991

    Google Scholar 

  • O’Hare JA. Effect of captoprit on diabetic proteinuria. Correspondence. New England Journal of Medicine 315: 515, 1986

    Google Scholar 

  • O’Hare JP, Capps N, Bottomley S, Sykes J, Sewell G, et al. Low dose captopril reduces proteinuria in diabetic nephropathy without reducing blood pressure. Abstract. Diabetic Medicine 5 (Suppl. 5): 1, 1988

    Google Scholar 

  • Ohnishi A, Ishizaki T, Murakami S, Tanaka T. Intrapatient comparison of acute hemodynamic hormonal, and natriuretic responses to captopril versus enalapril in liver cirrhosis. Clinical Pharmacology and Therapeutics 48: 67–75, 1990

    PubMed  CAS  Google Scholar 

  • Ondetti MA. Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity. Circulation 77 (Suppl, I): 174–178, 1988

    Google Scholar 

  • Panzram G. Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123–131, 1987

    PubMed  CAS  Google Scholar 

  • Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 14: 260–269, 1991

    PubMed  CAS  Google Scholar 

  • Parving H-H, Andersen AR, Hommel E, Smidt UM. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 7 (Suppl. II): I14–I17, 1985

    Google Scholar 

  • Parving H-H, Andersen JR, Smidt UM, Christiansen JS, Oxenboll B, et al. Diabetic nephropathy and arterial hypertension: the effect of antihypertensive treatment. Diabetes 32 (Suppl. 2): 83–87, 1983a

    PubMed  Google Scholar 

  • Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen E, et al. Effects of antihypertensive treatment on kidney function in diabetic nephropathy. British Medical Journal 294: 1443–1447, 1987

    PubMed  CAS  Google Scholar 

  • Parving H-H, Andersen AR, Smidt UM, Oxenboll B, Edsbert B, et al. Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10–12, 1983b

    PubMed  CAS  Google Scholar 

  • Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early and aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1178, 1983c

    PubMed  CAS  Google Scholar 

  • Parving H-H, Gall M-A, Skott P, Jorgensen HE, Jorgensen F, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic (NIDDM) patients. Abstract. Diabetologia 33: 48A, 1990

    Google Scholar 

  • Parving H-H, Hommel E, Nielsen MD, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. British Medical Journal 299: 533–536, 1989

    PubMed  CAS  Google Scholar 

  • Parving H-H, Hommel E, Smidt UM. Angiotensin converting enzyme inhibition protects kidney function and reduces albuminuria in diabetic nephropathy. Abstract. Diabetologia 31: 530A, 1988a

    Google Scholar 

  • Parving H-H, Hommel E, Smidt UM. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. British Medical Journal 297: 1086–1091, 1988b

    PubMed  CAS  Google Scholar 

  • Pasanisi F, Vaccaro O, Ferrara AL, Di Bonito P, Capaldo B, et al. Effects of nicardipine on insulin secretion, glucose and lipid metabolism in hypertensive, non-insulin dependent diabetes. European Journal of Clinical Pharmacology 36: 1–4, 1989

    PubMed  CAS  Google Scholar 

  • Passa P, Leblanc H, Marre M. Effects of enalapril in insulin-dependent diabetic subjects with mild and moderate uncomplicated hypertension. Diabetes Care 10: 200–204, 1987

    PubMed  CAS  Google Scholar 

  • Pedersen MM, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabetic Medicine 5: 562–569, 1988

    PubMed  CAS  Google Scholar 

  • Pedrinelli R, Fouad FM, Tarazi RC, Bravo EL, Textor SC. Nitrendipine, a calcium-entry blocker: renal and humoral effects in human arterial hypertension. Archives of Internal Medicine 146: 62–65, 1986

    PubMed  CAS  Google Scholar 

  • Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. New England Journal of Medicine 319: 80–86, 1988

    PubMed  CAS  Google Scholar 

  • Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. New England Journal of Medicine 321: 868–873, 1989a

    PubMed  CAS  Google Scholar 

  • Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39: 167–174, 1990

    PubMed  CAS  Google Scholar 

  • Pollare T, Lithell H, Morlin C, Prantare H, Hvarfner A, et al. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. Journal of Hypertension 7: 551–559, 1989b

    PubMed  CAS  Google Scholar 

  • Pollare T, Lithell H, Selinus I, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31: 415–420, 1988

    PubMed  CAS  Google Scholar 

  • Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. British Medical Journal 298: 1152–1157, 1989c

    PubMed  CAS  Google Scholar 

  • Pool JL, Gennari J, Goldstein R, Kochor MS, Lewin AJ, et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. Journal of Cardiovascular Pharmacology 9 (Suppl. 3): S36–S42, 1987

    PubMed  Google Scholar 

  • Prince MJ, Stuart CA, Padia M, Bandi Z, Holland OB. Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient: enalapril for hypertensive diabetics. Archives of Internal Medicine 148: 2363–2368, 1988

    PubMed  CAS  Google Scholar 

  • Reams G, Hamory A, Lau A, Bauer JH. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 11: 452–456, 1988

    PubMed  CAS  Google Scholar 

  • Reaven GM, Hoffman BB. A role of insulin in the aetiology and course of hypertension? Lancet 2: 435–437, 1987

    PubMed  CAS  Google Scholar 

  • Reddi AS, Camerini-Davalos RA. Diabetic nephropathy: an update. Archives of Internal Medicine 150: 31–43, 1990

    PubMed  CAS  Google Scholar 

  • Rett K, Wicklmayr M, Dietze GJ. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides and captopril. Correspondence. New England Journal of Medicine 319: 1609, 1988a

    PubMed  CAS  Google Scholar 

  • Rett K, Wicklmayr M, Tschollar G, Dietze G, Mehnert H. Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus. Postgraduate Medical Journal 64 (Suppl. 3): 69–73, 1988b

    PubMed  Google Scholar 

  • Romanelli G, Giustina A, Agabiti-Rosei E, Bossoni S, Girelli A, et al. Short-term effect of captopril and nifedipine on microal-buminuria induced by exercise in hypertensive diabetic patients. Journal of Hypertension 6 (Suppl. 6): S312–S313, 1989

    Google Scholar 

  • Romero JC, Raij L, Granger JP, Ruilope LM, Rodicio JL. Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension 10: 140–151, 1987

    PubMed  CAS  Google Scholar 

  • Rosenstock J, Raskin P. Early diabetic nephropathy: assessment and potential therapeutic interventions. Diabetes Care 9: 529–545, 1986

    PubMed  CAS  Google Scholar 

  • Ross EA. Effect of captopril on diabetic proteinuria. Correspondence. New England Journal of Medicine 315: 515, 1986

    Google Scholar 

  • Rowe JW, Young JB, Ninaker KL, Stevens AL, Pallotta J, et al. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219–225, 1981

    PubMed  CAS  Google Scholar 

  • Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 33: 470–476, 1990

    PubMed  CAS  Google Scholar 

  • Rudberg S, Dahlquist G, Aperia A, Persson B. Reduction of protein intake decreases glomerular filtration rate in young Type 1 (insulin-dependent) diabetic patients mainly in hyperfiltering patients. Diabetologia 31: 878–883, 1988

    PubMed  CAS  Google Scholar 

  • Saad M, Lillioja S, Nyomba BL, Castillo C, Ferraro R, et al. Racial difference in the relation between blood pressure and insulin resistance. New England Journal of Medicine 324: 733–739, 1991

    PubMed  CAS  Google Scholar 

  • Salvetti A. Newer ACE inhibitor: a look at the future. Drugs 40: 800–828, 1990

    PubMed  CAS  Google Scholar 

  • Sawicki PT, Heinemann L, Berger M. Hyperinsulinaemia in patients with insulinoma is not associated with elevated blood pressure value. Abstract. Diabetologia 34 (Suppl. 2): A20, 1991

    Google Scholar 

  • Sawicki PT, Mühlhauser I, Baba T, Berger M. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia 33: 121–124, 1990

    PubMed  CAS  Google Scholar 

  • Sawicki P, Mühlhauser I, Grabensee B, Berger M. Effect of captopril on diabetic proteinuria. Correspondence. New England Journal of Medicine 315: 516, 1986

    Google Scholar 

  • Schlueter WA, Batlle DC. Renal effects of antihypertensive drugs. Drugs 37: 900–925, 1989

    PubMed  CAS  Google Scholar 

  • Schmitz A, Gundersen HJG, Osterby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus: lack of glomerular hypertrophy. Diabetes 37: 38–43, 1988

    PubMed  CAS  Google Scholar 

  • Schmitz A, Pedersen MM, Mogensen CE. Effects of felodipine on urinary albumin excretion and metabolic control in hypertensive non-insulin-dependent diabetics. American Journal of Hypertension 3: 611–617, 1990

    PubMed  CAS  Google Scholar 

  • Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Medicine 5: 126–134, 1988

    PubMed  CAS  Google Scholar 

  • Schoen RE, Frishman WH, Shamoon H. Hormonal and metabolic effects of calcium channel antagonists in man. American Journal of Medicine 84: 492–504, 1988

    PubMed  CAS  Google Scholar 

  • Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. New England Journal of Medicine 320: 1161–1165, 1989

    PubMed  CAS  Google Scholar 

  • Shen DC, Sheh SM, Fuh MMT, Wu DA. Resistance to insulinstimulated-glucose uptake in patients with hypertension. Journal of Clinical Endocrinology and Metabolism 66: 580–583, 1988

    PubMed  CAS  Google Scholar 

  • Singer P, Godicke W, Voigt S, Jajdu I, Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 7: 182–186, 1985

    PubMed  CAS  Google Scholar 

  • Skøtt P, Horther-Nielsen O, Bruun NE, Giese J, Nielsen MD, et al. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 32: 694–699, 1989

    PubMed  Google Scholar 

  • Skott P, Vaag A, Bruun NE, Hother-Nielsen O, Gall M-A, et al. Effects of insulin on renal sodium handling in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance. Diabetologia 34: 275–281, 1991

    PubMed  CAS  Google Scholar 

  • Sowers JR, Levy J, Zemel MB. Hypertension and diabetes. Medical Clinics of North America 72: 1399–1414, 1988

    PubMed  CAS  Google Scholar 

  • Sowers JR, Zemel MB. Clinical implications of hypertension in the diabetic patient. American Journal of Hypertension 3: 415–424, 1990

    PubMed  CAS  Google Scholar 

  • Stein PP, Black HR. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 14: 425–448, 1991

    PubMed  CAS  Google Scholar 

  • Sunderrajan S, Reams G, Bauer JH. Long-term effects of diltiazem in essential hypertension. American Heart Journal 114: 383–388, 1987

    PubMed  CAS  Google Scholar 

  • Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, et al. Effect of captopril on heavy proteinuria in azotemic diabetics. New England Journal of Medicine 313: 1617–1620, 1985

    PubMed  CAS  Google Scholar 

  • Tentorio A, Ghilardi G, Pedroncelli A, Benco R, Stroppa S, et al. Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment. European Journal of Clinical Pharmacology 36: 311–313, 1989

    PubMed  CAS  Google Scholar 

  • Tierney WM, Harris LE, Copley JB, Luft FC. Effect of hypertension and Type II diabetes on renal function in an urban population. American Journal of Hypertension 3: 69–75, 1990

    PubMed  CAS  Google Scholar 

  • Trost BN. Hypertension in the diabetic patient: selection and optimum use of antihypertensive drugs. Drugs 38: 621–633, 1989

    PubMed  CAS  Google Scholar 

  • Trost BN, Weidmann P. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review. Journal of Hypertension 5: S81–S104, 1987

    PubMed  CAS  Google Scholar 

  • Tsutsu N, Nunoi K, Kodama T, Nomiyama R, Iwase M, et al. Lack of association between blood pressure and insulin in patients with insulinoma. Journal of Hypertension 8: 479–482, 1990

    PubMed  CAS  Google Scholar 

  • Tung P, Levin SR. Nephropathy in non-insulin dependent diabetes mellitus. American Journal of Medicine 85 (Suppl. 5A): 131–136, 1988

    PubMed  CAS  Google Scholar 

  • Unger T, Gohlke P, Ganten D, Lang RE. Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall. Journal of Cardiovascular Pharmacology 13 (Suppl. 3): S8–S16, 1989

    PubMed  Google Scholar 

  • United Kingdom Prospective Diabetes Study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 7 (Suppl. 2): II5–II13, 1985

    Google Scholar 

  • Uusitupa M, Siitonen O, Penttila I, Aro A, Pyorala K. Proteinuria in newly diagnosed Type II diabetic patients. Diabetes Care 10: 191–194, 1987

    PubMed  CAS  Google Scholar 

  • Valvo E, Bedogna V, Casagrande P, Antiga L, Zamboni M, et al. Captopril in patients with Type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. American Journal of Medicine 85: 344–348, 1988

    PubMed  CAS  Google Scholar 

  • Veterans Administration Cooperative Study Group on Anti-hypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. Journal of American Medical Association 248: 1996–2003, 1982

    Google Scholar 

  • Viberti GC, Bilous RW, Mackintoch B, Bending JJ, Keen H. Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. British Medical Journal 286: 598–602, 1983

    PubMed  CAS  Google Scholar 

  • Viberti GC, Hill RD, Jarrett RD, Argyropoulos A, Mahmud U, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432, 1982

    PubMed  CAS  Google Scholar 

  • Viberti GC, Keen H. Review: the patterns of proteinuria in diabetes mellitus. Diabetes 33: 686–692, 1984

    PubMed  CAS  Google Scholar 

  • Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent patients. British Medical Journal 195: 575–577, 1987

    Google Scholar 

  • Walker JD, Tariq T, Viberti GC. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. British Medical Journal 301: 635–638, 1990

    PubMed  CAS  Google Scholar 

  • Webster MWI, Fitzpatrick MA, Nicholls MG, Ikram H, Wells JE. Effect of enalapril on ventricular arrhythmias in congestive heart failure. American Journal of Cardiology 56: 566–569, 1985

    PubMed  CAS  Google Scholar 

  • Weinberger MH. Blood pressure and metabolic responses to hydrochlorthiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. Journal of Cardiovascular Pharmacology 7 (Suppl. 1): S52–S55, 1985

    PubMed  Google Scholar 

  • Weinberger MH. Racial differences in antihypertensive therapy: evidence and implications. Cardiovascular Drugs Therapy 4: 379–382, 1990

    Google Scholar 

  • Williams GH. Converting-enzyme inhibition in the treatment of hypertension. New England Journal of Medicine 319: 1517–1525, 1988

    PubMed  CAS  Google Scholar 

  • Winocour P, Waldek S, Johns CW, Dhar H, Anderson DC. Captopril may adversely affect renal function in hypertensive diabetics without established nephropathy. Journal of Endocrinology 108 (Suppl.): 216, 1986

    Google Scholar 

  • Wiseman M, Viberti GC, Mackintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and microalbuminuria in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 14: 401–405, 1984

    Google Scholar 

  • Working Group on Hypertension in Diabetics. Statement on hypertension in diabetes. Diabetes Care 10: 764–776, 1987a

    Google Scholar 

  • Working Group on Hypertension in Diabetics. Statement on hypertension in diabetes. Archives of Internal Medicine 147: 830–842, 1987b

    Google Scholar 

  • Wright AD, Barber SG, Kendall MJ, Poole PH. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. British Medical Journal 1: 151–161, 1979

    Google Scholar 

  • Yudkin JS, Rorrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Inslington Diabetes Survey. Lancet 2: 530–533, 1988

    PubMed  CAS  Google Scholar 

  • Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. Journal of Clinical Investigation 77: 1925–1930, 1986

    PubMed  CAS  Google Scholar 

  • Zavaroni I, Bonora E, Pagliara M, Dall’Aglio E, Luchetti L, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. New England Journal of Medicine 320: 702–706, 1989

    PubMed  CAS  Google Scholar 

  • Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the regression of renal failure in patients with insulin-dependent diabetes mellitus. New England Journal of Medicine 324: 78–84, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan

    Tsuneharu Baba &  Takashi Ishizaki

  2. Division of Clinical Pharmacology, Clinical Research Institute, National Medical Center, Toyama 1-21-2, Shinjuku-ku, Tokyo, 162, Japan

    Tsuneharu Baba &  Takashi Ishizaki

Authors
  1. Tsuneharu Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Ishizaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baba, T., Ishizaki, T. Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy. Drugs 43, 464–489 (1992). https://doi.org/10.2165/00003495-199243040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199243040-00004

Keywords

Search

Navigation